ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0552

Presence of MAIT Cells in Synovial Tissue of Patients with Axial Spondyloarthritis: A Comparative Study

Andre Ramon1, Philippe Saas2, Charline Vauchy3, Maxime Samson2 and ERIC TOUSSIROT4, 1Dijon University Hospital, Besançon, France, 2Franche-Comté University, EFS, INSERM, UMR RIGHT, Besançon, France, Besançon, France, 3INSERM CIC-1431, CHU de Besançon, Besancon, France, Besançon, France, 4university hospital of BESANCON, besancon, France

Meeting: ACR Convergence 2024

Keywords: spondyloarthritis, Synovitis, T-Lymphocyte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Mucosal-associated invariant T (MAIT) cells are innate immune T cells that are located at the mucosal barriers. They play a role in mucosal defense, especially against bacterial pathogens. They are able to produce inflammatory cytokines with a mixed Th1/Th17-like response, including TNF-a and IL-17A. MAIT cells have been implicated in the pathophysiology of axial spondyloarthritis (axSpA). Indeed, recent studies showed a higher frequency of MAIT cells in the peripheral blood of patients with axSpA, especially MAIT cells expressing IFN-g, TNF-a, IL-17A and IL-22. Thus, MAIT cells are considered to be a source of IL-17A and IL-22, two cytokines involved in the inflammatory process and bone formation of axSpA, respectively. Previous studies in axSpA evaluated circulating MAIT cells, but not their presence at the pathological sites of inflammation. Thus, we aimed to evaluate the expression of MAIT cells in synovial biopsies from patients with axSpA.

Methods: synovial tissue samples were obtained during surgical procedure for joint arthroplasty. Patients evaluated were axSpA (ASAS criteria) and compared to patients with rheumatoid arthritis (RA). We also included a control group of patients with osteoarthritis (OA) and a positive control group with the previously reported MAIT expression at a tissue level, i.e. giant cell arteritis (GCA). MAIT cells were defined by CD3+ TCRVa7.2+ CD161+ phenotype. Using confocal microscopy, MAIT cells in synovial tissue (axSpA, RA, OA) and in temporal artery biopsies (GCA) were identified by the co-staining of CD3, TCRva7.2 and IL-18R using primary antibodies.

Results: 11 patients were evaluated: 3 patients with axSpA (2 nr-axSpA; 3 males; age [mean]: 62.6 years; disease duration [mean]: 16.3 years; two under TNFi, one under NSAIDs; BASDAI [mean]: 5.6; ASDAS [mean]: 3.05); 3 with RA (1 male; age: 69.3; disease duration: 14.3; 1 under MTX, 2 under ts/bDMARDs); 4 with OA (2 males; age: 65) and 1 with GCA. Synovial biopsies were obtained from hip (n=5), knee (n = 3), shoulder (n = 1) or hand (MCP) (n=1) joints. GCA positive control artery revealed a strong infiltrate of CD3+ T cells. Among these cells, few cells co-expressed CD3, IL-18R and TCRva7.2. In synovial tissue, CD3 staining revealed a weakest infiltrate of CD3+ T cells, especially in OA synovial samples. MAIT cells were present in a low proportion in one sample from axSpA patients (fig 1), while no MAIT cells were observed in RA and OA samples.

Conclusion: MAIT are observed in synovial tissue of an axSpA patient suggesting their potential contribution to local cytokine production and inflammatory response. They are represented in a low proportion and this may be related to disease duration and/or the treatments. Additional analysis on other relevant site of inflammation of axSpA, i.e. entheseal structures and in patients with shorter disease duration, are required.

Reference :

1-     1- Ghesquière T et al. J Autoimmun. 2021.

2-     2- Rosine N et al. Arthritis Rheumatol. 2022.

Supporting image 1

Figure 1: MAIT cells (CD3+IL_18R+TCRvα7.2+) (arrows) in synovial tissue from a patient with axSpA (nr-axSpA, HLA B27+, under NSAIDs, with low/high disease activity: BASDAI: 3.8, ASDAS: 2,15).


Disclosures: A. Ramon: None; P. Saas: None; C. Vauchy: None; M. Samson: None; E. TOUSSIROT: None.

To cite this abstract in AMA style:

Ramon A, Saas P, Vauchy C, Samson M, TOUSSIROT E. Presence of MAIT Cells in Synovial Tissue of Patients with Axial Spondyloarthritis: A Comparative Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/presence-of-mait-cells-in-synovial-tissue-of-patients-with-axial-spondyloarthritis-a-comparative-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-mait-cells-in-synovial-tissue-of-patients-with-axial-spondyloarthritis-a-comparative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology